Past Events
Understanding PBM Reform: A Guide to Congress’s Proposals to Enact Federal PBM Reform Legislation
After the enactment of the Inflation Reduction Act, which enables Medicare to negotiate the price of certain prescription drugs, Congress is again attempting to lower the cost of prescription drugs. This time—in a rare bipartisan effort—Congress is focusing on pharmacy benefit managers (PBMs). PBMs are third-party “middlemen” contracted by insurance plans to manage prescription drug […]
Will the A.I. Future Be Inclusive?
Many commentators have sounded the alarm about bias in artificial intelligence and other digital technology. But what if such technology could instead be a powerful tool to advance diversity, equity, and inclusion? In her book The Equality Machine, legal and tech scholar Orly Lobel argues that digital technology holds tremendous promise—it can detect discrimination, close pay […]
Tuesday, October 3, 2023
Navigating the Mainstreaming of Psychedelic Drugs in the United States
In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold. In the United States, many types of psychedelics are being investigated for use in treating an array of mental health conditions. The U.S. nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS) has announced promising phase 3 clinical trial results for […]
Telehealth Licensure: Emerging State Models of Physician Licensure Flexibility for Telehealth
COVID-19 greatly accelerated the adoption of telehealth, and now three years later, states are exploring new policies to expand or streamline the state licensure process for physicians while ensuring continued authority to regulate and oversee the practice of medicine. In a new webinar, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH will moderate a panel […]
Mental Health Parity Update: Key Takeaways From the Newest Regulatory Guidance and Litigation Trends
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide mental health benefits, including coverage for substance use disorders (SUDs), that are in “parity” with medical and surgical benefits. The exploding opioid and SUD crisis coupled with the soaring rates of mental health conditions post-COVID have put mental health parity in […]
The Legal, Regulatory and Market Trends Transforming Health Care
From the end of the COVID-19 public health emergency (PHE) to the overturning of Roe v. Wade to the skyrocketing growth of virtual care, multiple forces are converging to remap the health care landscape. In a new webinar, Manatt Health will draw on the deep-dive legal, policy and market analyses in its Manatt on Health premium information service to […]
Emerging Fraudulent Schemes in Health Care: A Guide to Protecting Plan and Provider Organizations
Over the past few years, there has been tightening enforcement and numerous lawsuits driven by the increasingly complex web of federal and state anti-kickback and anti-inducement statutes. In a new CLE-eligible webinar, Manatt Health will guide plans and providers through the emerging landscape of fraudulent health care schemes—and provide practical answers to the legal questions […]
Achieving Diversity in Clinical Trials: Expanding the Role of Community Hospitals
The inclusion of racial and ethnic groups in clinical trials has been a national priority for decades, but progress toward that goal has been limited. When the COVID-19 pandemic threw into stark relief the underlying inequities in health care access (and therefore in clinical trial access), Congress and the Administration were moved to action. In […]
Medicaid Coverage Opportunities for Justice-Involved Populations: CMS Guidance and States’ Approaches
Individuals leaving incarceration have disproportionately higher rates of physical and behavioral health diagnoses and are at higher risk for injury and death compared with people who have not been incarcerated. Race disparities in incarceration further exacerbate health inequities for people of color upon release. Justice-involved individuals often will be released into the community with no […]
False Claims Act 2023: What Every Health Care Entity Working with the Government Needs to Know
Tuesday, July 181:00 p.m.–2:00 p.m. ET Of the $2.2 billion in False Claims Act (FCA) settlements and judgments that the Department of Justice (DOJ) reported in fiscal year 2022, $1.7 billion related to matters involving the health care industry. That staggering number reflects only federal losses, with the DOJ recovering additional amounts for state Medicaid […]